Barclays Lowers Bruker (NASDAQ:BRKR) Price Target to $65.00
Bruker (NASDAQ:BRKR – Get Free Report) had its price target lowered by stock analysts at Barclays from $69.00 to $65.00 in a research note issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price target points to a potential upside of 28.33% from the stock’s previous […]
Bruker (NASDAQ:BRKR – Get Free Report) had its price target lowered by stock analysts at Barclays from $69.00 to $65.00 in a research note issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price target points to a potential upside of 28.33% from the stock’s previous […]
